Arch Venture Partners Ix, Llc - Net Worth and Insider Trading

Arch Venture Partners Ix, Llc Net Worth

The estimated net worth of Arch Venture Partners Ix, Llc is at least $1.1 Billion dollars as of 2024-04-28. Arch Venture Partners Ix, Llc is the 10% Owner of Karuna Therapeutics Inc and owns about 3,362,872 shares of Karuna Therapeutics Inc (KRTX) stock worth over $1.1 Billion. Details can be seen in Arch Venture Partners Ix, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arch Venture Partners Ix, Llc has not made any transactions after 2019-07-02 and currently still holds the listed stock(s).

Transaction Summary of Arch Venture Partners Ix, Llc

To

Arch Venture Partners Ix, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arch Venture Partners Ix, Llc owns 6 companies in total, including Beam Therapeutics Inc (BEAM) , Vir Biotechnology Inc (VIR) , and Karuna Therapeutics Inc (KRTX) among others .

Click here to see the complete history of Arch Venture Partners Ix, Llc’s form 4 insider trades.

Insider Ownership Summary of Arch Venture Partners Ix, Llc

Ticker Comapny Transaction Date Type of Owner
BEAM Beam Therapeutics Inc 2020-02-05 10 percent owner
VIR Vir Biotechnology Inc 2021-03-30 10 percent owner
KRTX Karuna Therapeutics Inc 2019-07-02 10 percent owner
GOSS Gossamer Bio Inc 2019-02-07 10 percent owner
SANA Sana Biotechnology Inc 2021-02-03 10 percent owner
LYEL Lyell Immunopharma Inc 2021-06-16 10 percent owner

Arch Venture Partners Ix, Llc Latest Holdings Summary

Arch Venture Partners Ix, Llc currently owns a total of 1 stock. Arch Venture Partners Ix, Llc owns 3,362,872 shares of Karuna Therapeutics Inc (KRTX) as of July 2, 2019, with a value of $1.1 Billion.

Latest Holdings of Arch Venture Partners Ix, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KRTX Karuna Therapeutics Inc 2019-07-02 3,362,872 329.83 1,109,176,072

Holding Weightings of Arch Venture Partners Ix, Llc


Arch Venture Partners Ix, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Arch Venture Partners Ix, Llc has made a total of 1 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Karuna Therapeutics Inc is the acquisition of 200,000 shares on July 2, 2019, which cost Arch Venture Partners Ix, Llc around $3 Million.

Insider Trading History of Arch Venture Partners Ix, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Arch Venture Partners Ix, Llc Trading Performance

GuruFocus tracks the stock performance after each of Arch Venture Partners Ix, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arch Venture Partners Ix, Llc is -35.67%. GuruFocus also compares Arch Venture Partners Ix, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arch Venture Partners Ix, Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Arch Venture Partners Ix, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Arch Venture Partners Ix, Llc

Average Return

403.48%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.36 -35.67 234.75 403.48 135.43 79.78
Relative Return to S&P 500(%) -11.98 -32.8 225.17 398.21 114.47 71.01

Arch Venture Partners Ix, Llc Ownership Network

Ownership Network List of Arch Venture Partners Ix, Llc

No Data

Ownership Network Relation of Arch Venture Partners Ix, Llc


Arch Venture Partners Ix, Llc Owned Company Details

What does Beam Therapeutics Inc do?

Who are the key executives at Beam Therapeutics Inc?

Arch Venture Partners Ix, Llc is the 10 percent owner of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include Chief Medical Officer Amy Simon , President & CSO Giuseppe Ciaramella , and CFO Terry-ann Burrell .

Beam Therapeutics Inc (BEAM) Insider Trades Summary

Over the past 18 months, Arch Venture Partners Ix, Llc made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 114,771 shares made by Terry-ann Burrell , a net sale of 17,788 shares made by Christine Bellon , and a net sale of 215,751 shares made by Giuseppe Ciaramella .

In summary, during the past 3 months, insiders sold 1,016,735 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 1,016,735 shares. During the past 18 months, 1,433,256 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,433,256 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Beam Therapeutics Inc Insider Transactions

No Available Data

Arch Venture Partners Ix, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Arch Venture Partners Ix, Llc. You might contact Arch Venture Partners Ix, Llc via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.

Discussions on Arch Venture Partners Ix, Llc

No discussions yet.